EP Patent

EP1681068A1 — Anti-pathogen and anti-cancer filtering device and method comprising nitric oxide

Assigned to Nolabs AB · Expires 2006-07-19 · 20y expired

What this patent protects

A filtering device and method are disclosed being adapted to eliminate, inactivate and/or remove pathogenic or cancerous elements, especially microorganisms, such as bacteria, parasites, fungi, mycoplasma, protozoa and viruses, or tumour cells from fluids, especially body fluids …

USPTO Abstract

A filtering device and method are disclosed being adapted to eliminate, inactivate and/or remove pathogenic or cancerous elements, especially microorganisms, such as bacteria, parasites, fungi, mycoplasma, protozoa and viruses, or tumour cells from fluids, especially body fluids or fluids getting into contact with the body, by using NO originating from the filtering device material. Exemplary embodiments comprise blood filters, or breathing gas filters.

Drugs covered by this patent

Patent Metadata

Patent number
EP1681068A1
Jurisdiction
EP
Classification
—
Expires
2006-07-19
Drug substance claim
No
Drug product claim
No
Assignee
Nolabs AB
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.